Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Continental Chemicals Limited submitted the newspaper copies of its unaudited financial results for the quarter and nine months ended 31 December 2025 to BSE, as required under SEBI LODR Regulation 47. The Board approved the results on 12 January 2026 and they were published in English and Hindi newspapers on 13 January 2026. Revenue from operations jumped to Rs 4,361 lakhs in Q3 FY26 from Rs 1,744 lakhs in Q3 FY25, while 9-month revenue rose modestly to Rs 12,392 lakhs vs Rs 11,738 lakhs. Net profit after tax grew to Rs 1,344 lakhs in Q3 (vs Rs 1,075 lakhs) and to Rs 3,942 lakhs for 9 months (vs Rs 2,900 lakhs). Basic and diluted EPS for 9 months stood at Rs 1.75 versus Rs 1.08 in the prior year. The company operates in a single segment and has equity share capital of Rs 224.90 lakhs.
Sharp Q3 revenue growth (~2.5x YoY) and 36% jump in 9-month net profit signal strong operational momentum, likely supportive of investor sentiment; however, the filing itself is a routine newspaper publication compliance and does not directly move the stock.